Amcor, Emerson Electric And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, picked the iShares Biotechnology ETF (NYSE:IBB), and recommended staying long on biotech.

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, said Amcor plc (NYSE:AMCR) reported great quarterly earnings and has a 5.5% yield.

Amcor, on Feb. 3, reported second-quarter earnings of 86 cents per share, which beat the analyst consensus estimate of 85 cents per share. The company reported quarterly sales of $5.449 billion, which missed the analyst consensus estimate of $5.576 billion.

Don't forget to check out our premarket coverage here

Liz Thomas, SoFi’s head of investment strategy, named Vanguard Emerging Markets Stock Index Fund (NYSE:VWO) as her final trade.

Joe Terranova, senior managing director for Virtus Investment Partners, recommended Emerson Electric Co. (NYSE:EMR), an industrial name.

Lending support to his choice, Emerson Electric, on Tuesday, reported better-than-expected first-quarter adjusted EPS results and raised its FY26 EPS guidance. Emerson Electric reported quarterly earnings of $1.46 per share, which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $4.346 billion compared to the analyst consensus estimate of $4.347 billion.

Price Action:

• iShares Biotechnology ETF gained 0.1% on Wednesday.
• Amcor shares gained 8.1% to close at $48.56 during the session.
• Vanguard Emerging Markets Stock Index Fund fell 0.6% on Wednesday.
• Emerson Electric shares gained 3.4% to settle at $157.32 during the session.

Photo: Shutterstock